CSIR Central

Anti-cancer Investigation of Newly Derived Alicyclic ring and Morpholine Supported Hybrid Molecules by Industrially viable Route

IR@NISCAIR: CSIR-NISCAIR, New Delhi - ONLINE PERIODICALS REPOSITORY (NOPR)

View Archive Info
 
 
Field Value
 
Title Anti-cancer Investigation of Newly Derived Alicyclic ring and Morpholine Supported Hybrid Molecules by Industrially viable Route
 
Creator Kapadiya, K
Pandya, M
Rathod, C
Dhalani, J
Dhaduk, B
 
Subject Cyclopropane
Anticancer Screening
Ugi Multicomponent Reaction
Morpholinoethyl Isocyanide
 
Description 219-224
In an attempt to design and synthesize a new class of anticancer molecules, we have reported coupling of aryl aldehyde, <em>p</em>-toluidine and morpholine based isocyanide with cyclopropane carboxylic acid to generate a small library of 08 compounds (5a-5h) by ugi multicomponent reaction in a single step manner. Structures of the newly synthesized compounds were recognized on the basis of spectral data <em>i.e.</em> <sup>1</sup>H NMR, <sup>13</sup>C NMR, IR and Mass. These compounds were screened for their anticancer activity against nine basic panels as well as NCI-60 cell-lines. <em>In vitro </em> anticancer studies revealed that the compound 5ashowed maximum potency against HCT-116 in colon cancer cell lines with GI<sub>50</sub> values 46.27 µg/ml.
 
Date 2018-04-04T08:48:39Z
2018-04-04T08:48:39Z
2018-04
 
Type Article
 
Identifier 0975-1084 (Online); 0022-4456 (Print)
http://nopr.niscair.res.in/handle/123456789/44150
 
Language en_US
 
Rights <img src='http://nopr.niscair.res.in/image/cc-license-sml.png'> <a href='http://creativecommons.org/licenses/by-nc-nd/2.5/in' target='_blank'>CC Attribution-Noncommercial-No Derivative Works 2.5 India</a>
 
Publisher NISCAIR-CSIR, India
 
Source JSIR Vol.77(04) [April 2018]